Effects of cytokine and cytokine receptor gene variation on high anti-HB titers: Following up on Taiwan's neonatal hepatitis B immunization program

Clinica Chimica Acta

Volumn 413, Issue 15-16, 2012, Pages 1194-1198

  Lin, Ying Ju ^a,b   Lan, Yu Ching ^b   Huang, Yu Chuen ^a,b   Lin, Ting Hsu ^a   Huang, Shao Mei ^a   Lai, Chien Chen ^c   Liu, Chiu Shong ^a   Lin, Cheng Wen ^b   Chen, Shih Yin ^a,b   Tsai, Fuu Jen ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B; High anti HB titer; IL 4 genetic polymorphisms; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RESPONSE; FOLLOW UP; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMAN; IL 4 GENE; IL 4R GENE; IMMUNIZATION; MAJOR CLINICAL STUDY; NEWBORN CARE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL; UPREGULATION;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; CYTOKINES; GENE FREQUENCY; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INTERLEUKIN-4; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4; TAIWAN; YOUNG ADULT;

EID: 84861337505     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.03.004     Document Type: Article

References (26)

1. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001, 135:796-800.
2. Shokri F., Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine 2001, 19:4544-4548.
3. Belloni C., Tinelli C., Orsolini P., Pistorio A., Avanzini A., Moretta A., et al. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine 1998, 16:399-402.
4. Lu J.J., Cheng C.C., Chou S.M., Hor C.B., Yang Y.C., Wang H.L. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009, 27:6613-6618.
5. Lu C.Y., Ni Y.H., Chiang B.L., Chen P.J., Chang M.H., Chang L.Y., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008, 197:1419-1426.
6. Lin Y.J., Lan Y.C., Wan L., Lin T.H., Chen D.Y., Tsai C.H., et al. Serological surveillance and IL-10 genetic variants on anti-HBs titers: hepatitis B vaccination 20 years after neonatal immunization in Taiwan. Clin Chim Acta 2011, 412:766-773.
7. Kimman T.G., Vandebriel R.J., Hoebee B. Genetic variation in the response to vaccination. Community Genet 2007, 10:201-217.
8. Yucesoy B., Johnson V.J., Fluharty K., Kashon M.L., Slaven J.E., Wilson N.W., et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009, 27:6991-6997.
9. Singh N., Agrawal S., Rastogi A.K. Infectious diseases and immunity: special reference to major histocompatibility complex. Emerg Infect Dis 1997, 3:41-49.
10. Lindemann M., Barsegian V., Siffert W., Ferencik S., Roggendorf M., Grosse-Wilde H. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology 2002, 297:245-252.
11. Dhiman N., Poland G.A., Cunningham J.M., Jacobson R.M., Ovsyannikova I.G., Vierkant R.A., et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007, 120:666-672.
12. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195:21-29.
13. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Ryan J.E., Pankratz V.S., Jacobson R.M., et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008, 26:1731-1736.
14. Ovsyannikova I.G., Reid K.C., Jacobson R.M., Oberg A.L., Klee G.G., Poland G.A. Cytokine production patterns and antibody response to measles vaccine. Vaccine 2003, 21:3946-3953.
15. Zhang W., Han L., Lin C., Wang H., Pang X., Li L., et al. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine. Vaccine 2011, 29:6276-6282.
16. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39:978-988.
17. Yucesoy B., Sleijffers A., Kashon M., Garssen J., de Gruijl F.R., Boland G.J., et al. IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine 2002, 20:3193-3196.
18. Hsu H.M., Lu C.F., Lee S.C., Lin S.R., Chen D.S. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999, 179:367-370.
19. Seder R.A., Paul W.E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994, 12:635-673.
20. Kelly-Welch A.E., Hanson E.M., Boothby M.R., Keegan A.D. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300:1527-1528.
21. Wiertsema S.P., Baynam G., Khoo S.K., Veenhoven R.H., van Heerbeek N., Zhang G., et al. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine 2007, 25:306-313.
22. Baynam G., Zhang G., Khoo S.K., Sly P., Holt P., Goldblatt J., et al. Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses. Vaccine 2008, 26:3574-3579.
23. Vingerhoets J., Vanham G., Kestens L., Penne G., Leroux-Roels G., Gigase P. Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production. Immunol Lett 1994, 39:163-168.
24. Larsen C.E., Xu J., Lee S., Dubey D.P., Uko G., Yunis E.J., et al. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen. Vaccine 2000, 18:3021-3030.
25. Tsutsui H., Mizoguchi Y., Morisawa S. There is no correlation between function and lymphokine production of HBs-antigen-specific human CD4(+)-cloned T cells. Scand J Immunol 1991, 34:433-444.
26. Jarrosson L., Kolopp-Sarda M.N., Aguilar P., Bene M.C., Lepori M.L., Vignaud M.C., et al. Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. Vaccine 2004, 22:3789-3796.